While the traditional approach to market success calls for patiently investing in reliable blue chips, those that want to see more immediate gains may consider small-cap stocks to buy. Here, the point is about accepting massive risk to hopefully realize massive rewards.

Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich

GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Present at 43rd Annual William Blair Growth Stock Conference.

Inogen to Present at 43rd Annual William Blair Growth Stock Conference

Inogen, Inc. (NASDAQ:INGN ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Agnes Lee – Senior Vice President-Investor Relations and Strategic Planning Nabil Shabshab – President and Chief Executive Officer Kristin Caltrider – Chief Financial Officer Conference Call Participants Mike Matson – Needham & Co. Matthew Mishan – KeyBanc Operator Welcome to Inogen's First Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode.

Inogen, Inc. (INGN) Q1 2023 Earnings Call Transcript

Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall first-quarter results reflect soft performances.

Inogen (INGN) Q1 Earnings Beat Estimates, Revenues Lag

While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings

Inogen (INGN) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $0.38 per share a year ago.

Inogen (INGN) Reports Q1 Loss, Lags Revenue Estimates

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.